Vancomycin-resistant enterococci: causes and control?

---

• 1.
• Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1: 57-58.
• 2.
• Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-161.
• 3.
• Kamarulzaman A, Tosolini FA, Boquest AL, et al. Vancomycin-resistant Enteroccus faecium infection in a liver transplant recipient [abstract]. Aust N Z J Med 1995: 25; 560.
• 4.
• Bell J, Turnidge J, Coombs G, O'Brien F. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell 1998; 22: 249-252.
• 5.
• Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175: 117-127.
• 6.
• Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-198.
• 7.
• Collignon PJ. Vancomycin-resistant enterococci and use of avoparcin in animal feed: is there a link? Med J Aust 1999; 171: 144-146.
• 8.
• Ferguson JK, Dalton CB, McGettigan P, Hill S. Antimicrobial resistance in animal enteric bacteria and human disease -- a review of the scientific literature. Commissioned report to the Joint Expert Technical Advisory Committee on Antibiotic Resistance. Canberra; National Health and Medical Research Council, 1998.
• 9.
• Woodford N, Adebiyi AMA, Palepou MFI, Cookson BD. Diversity of vanA glycopeptide resistance elements in enterococci from humans and non human sources. Antimicrob Agents Chemother 1998; 42: 502-508.
• 10.
• Jensen LB. Differences in the occurrence of two base pair variants of Tn1546 from vancomycin-resistant enterococci from humans, pigs, and poultry. Antimicrob Agents Chemother 1998; 42: 2463-2464.
• 11.
• Jensen LB, Ahrens P, Dons L, et al. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol 1998; 36: 437-442.
• 12.
• Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342: 76-79.
• 13.
• Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997; 24: 545-555.
• 14.
• Dahl KH, Simonsen GS, Olsvik O, Sundsfjord A. Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci. Antimicrob Agents Chemother 1999; 43: 1105-1110.
• 15.
• Lyddy MM, Smith HJ, Baird RW. Isolation of vancomycin-resistant enterococci in community-based patients [abstract]. Microbiol Aust 1998; 19 (4): A92.
• 16.
• Butt H, Bell J, Ferguson JK. Are vancomycin-resistant enterococci prevalent in Hunter region farm animals? [abstract]. Microbiol Aust 1997; 18(4): P04.8.
• 17.
• Robson J, Allen A, Jennings A, et al. The emergence of vancomycin resistant Enterococcus faecium (VRE) in an Australian hospital -- clinical and epidemiological features [abstract]. Aust N Z J Med 1998; 28: 712.
• 18.
• Bonten MJ, Hayden MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348: 1615-1619.
• 19.
• Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Int Med 1992; 117: 112-116.
• 20.
• HICPAC committee. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995; 23: 87-94.
• 21.
• Quale J, Landman D, Saurina G, et al. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996; 23: 1020-1025.
• 22.
• Robertson MB, Dartnell JGA, Korman TM, on behalf of the Victorian Drug Usage Evaluation Group. Vancomycin and teicoplanin use in Victorian hospitals. Med J Aust 1999; 171: 127-131.
• 23.
• Grayson ML, Grabsch EA, Johnson PDR, et al. Outcome of a screening program for vancomycin-resistant enterococcci in a hospital in Victoria. Med J Aust 1999; 171: 133-136.